Noveome Biotherapeutics INC
Regenerative medicine company
Based in PA
🤖
AI Overview
With $280K in lobbying spend across 13 quarterly filings, Noveome Biotherapeutics INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2018 to 2021.
$280K
Total Spend
4
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $90K |
| 2019 | $90K |
| 2020 | $90K |
| 2021 | $10K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations
- •Medical research and development issues, as follows:
- •H.R.3219, Department of Defense Appropriations Act, FY2018
- •Department of Defense Appropriations Act, FY2019
- •Public Law 115-141, Consolidated App
- •Medical research and development issues, as follows:
- •H.R.6157, Department of Defense Appropriations Act, FY2019
- •Public Law 115-141, Consolidated Appropriations Act, FY2018
- •Medical research and development issues, as follows:
- •H.R.6157, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019
- •Public Law 115-141, Consolidated A
- •Monitor Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Medical research and development issues
- •Public Law 115-245, Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, FY2019, Implementation of Medical research and development issues
- •Department of Defen
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.